Literature DB >> 6584987

Isolation and characterization of a CHO amino acid transport mutant resistant to melphalan (L-phenylalanine mustard).

A H Dantzig, M Fairgrieve, C W Slayman, E A Adelberg.   

Abstract

A mutant of Chinese hamster ovary cells, CHY-2, was isolated on the basis of its reduced ability to grow on a limiting concentration of leucine and was found to be defective in uptake of leucine via the sodium-independent L system. Consistent with published reports that the L system can mediate melphalan uptake, the D10 of the mutant for melphalan was increased threefold under conditions designed to limit drug uptake to the L system (brief exposure in sodium-free medium). Unlike a previously described melphalan-resistant CHO mutant (CHr), CHY-2 displays no cross-resistance to colchicine or puromycin. It differs from a second melphalan-resistant CHO mutant, melr, in its sensitivity to melphalan in the presence of high Na+, and from a melphalan-resistant mouse leukemic cell in possessing normal levels of intracellular glutathione. Thus, CHY-2 represents a new melphalan-resistant mutant class. The effect of the CHY-2 mutation is pleiotropic, involving significant reductions in amino acid uptake via the L, A and Ly+ (but not ASC) systems. The primary defect is unknown; however, the mutant possesses normal intracellular concentrations of Na+ and K+ and normal membrane fluidity. The growth rate of the mutant in standard medium is greatly reduced (generation time of 60 h vs. 24 h), although it can be improved by the addition of a supplement containing high concentrations of leucine, proline, and peptides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6584987     DOI: 10.1007/bf01534900

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  2 in total

1.  A genetic approach to the study of neutral amino acid transport in mammalian cells in culture.

Authors:  E Englesberg; J Moffett
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

2.  Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.

Authors:  J A Moscow; C A Swanson; K H Cowan
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.